These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 36104227)

  • 1. Successful Treatment of Saddle Pulmonary Thromboembolism in 23-Week Preterm Infant.
    Kimura S; Takahashi K; Kaneyasu H; Fujimoto Y; Ohta N; Okada S; Hasegawa S
    Int Heart J; 2022 Sep; 63(5):989-994. PubMed ID: 36104227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful pulmonary embolectomy of a saddle pulmonary thromboembolism in a preterm neonate.
    Kalaniti K; Lo Rito M; Hickey EJ; Sivarajan VB
    Pediatrics; 2015 May; 135(5):e1317-20. PubMed ID: 25896834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment of arterial thrombus in an extremely low-birth-weight preterm neonate.
    Kayıran PG; Gürakan B; Kayıran SM
    Pediatr Neonatol; 2013 Feb; 54(1):60-2. PubMed ID: 23445745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of low dose recombinant tissue-type plasminogen activator for the treatment of acute pulmonary thromboembolism: a randomized, multicenter, controlled trial.
    Wang C; Zhai Z; Yang Y; Wu Q; Cheng Z; Liang L; Dai H; Huang K; Lu W; Zhang Z; Cheng X; Shen YH;
    Chest; 2010 Feb; 137(2):254-62. PubMed ID: 19741062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombolytic therapy in preterm infants: Fifteen-year experience.
    Grizante-Lopes P; Garanito MP; Celeste DM; Krebs VLJ; Carneiro JDA
    Pediatr Blood Cancer; 2020 Oct; 67(10):e28544. PubMed ID: 32710708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of tissue plasminogen activator to treat intracardiac thrombosis in extremely low-birth-weight infants.
    Bose J; Clarke P
    Pediatr Crit Care Med; 2011 Nov; 12(6):e407-9. PubMed ID: 21131893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary artery thrombus in a premature neonate treated with recombinant tissue plasminogen activator.
    DeMeo SD; Sherwood A; Hornik CD; Goldberg RN; Cotten CM; Bidegain M
    J Perinatol; 2014 Jul; 34(7):569-71. PubMed ID: 24968902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of massive pulmonary embolism with recombinant tissue type plasminogen activator (rt-PA) in a pregnant woman with intact gravidity and preterm labour.
    Flossdorf T; Breulmann M; Hopf HB
    Intensive Care Med; 1990; 16(7):454-6. PubMed ID: 2125304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful Use of Thrombolysis in an Extremely Low Birth Weight, Premature Infant With Aortic Thrombosis.
    Samji N; Twiss J; Chan AKC; Bhatt MD
    J Pediatr Hematol Oncol; 2022 Jul; 44(5):e888-e891. PubMed ID: 35398856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Intracranial hemorrhage due to pulmonary thromboembolism in heparin therapy and therapeutic management of patients hospitalized with massive pulmonary embolism after discharge].
    Beşli F; Keçebaş M; Alişir MF; Güngören F
    Turk Kardiyol Dern Ars; 2013 Apr; 41(3):228-32. PubMed ID: 23703559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Intraoperative thrombolysis with rt-PA in massive pulmonary embolism during venous thrombectomy].
    Scheeren TW; Hopf HB; Peters J
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1994 Nov; 29(7):440-5. PubMed ID: 7819477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Short-term outcomes and their related risk factors of extremely preterm and extremely low birth weight infants in Guangdong province].
    Collaborative Study Group for Extremely Preterm and Extremely Low Birth Weight Infants
    Zhonghua Er Ke Za Zhi; 2019 Dec; 57(12):934-942. PubMed ID: 31795560
    [No Abstract]   [Full Text] [Related]  

  • 13. [Incidence and risk factors of severe intraventricular hemorrhage in very low and extremely low birth weight infants: a multi-center study].
    Reduction of Infection in Chinese Neonatal Intensive Care Units Using the Evidence-based Practice for Improving Quality Study Group
    Zhonghua Er Ke Za Zhi; 2019 Apr; 57(4):258-264. PubMed ID: 30934197
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical efficacy of low dose recombinant tissue-type plasminogen activator for the treatment of acute intermediate-risk pulmonary embolism.
    Zhang LY; Gao BA; Jin Z; Xiang GM; Gong Z; Zhang TT; Lu HF; Wang YQ; Gong Y; Lu C; Huang WL
    Saudi Med J; 2018 Nov; 39(11):1090-1095. PubMed ID: 30397707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early intracardiac thrombosis in preterm infants and thrombolysis with recombinant tissue type plasminogen activator.
    Ferrari F; Vagnarelli F; Gargano G; Roversi MF; Biagioni O; Ranzi A; Cavazzuti GB
    Arch Dis Child Fetal Neonatal Ed; 2001 Jul; 85(1):F66-9. PubMed ID: 11420328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [An economic evaluation of low dose recombinant human tissue-type plasminogen activator for the treatment of acute pulmonary thromboembolism].
    Wu YQ; Tao LB; Lü C; Hu YH
    Zhonghua Yi Xue Za Zhi; 2010 Jan; 90(2):103-6. PubMed ID: 20356492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of low-dose prolonged infusion of tissue plasminogen activator in a nonagenarian patient with acute pulmonary embolism and main pulmonary artery thrombus.
    Yildiz M; Karakoyun S; Acar RD; Ozkan M
    Blood Coagul Fibrinolysis; 2013 Jan; 24(1):95-6. PubMed ID: 23037320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical analysis of 165 extremely low birth weight infants].
    Zhuang Y; Gao X; Liu X; Xiong Y; Liu Y; Zhang Q
    Zhonghua Er Ke Za Zhi; 2014 Oct; 52(10):736-40. PubMed ID: 25537537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant tissue plasminogen activator for massive pulmonary thromboembolism.
    Samejima K; Takai Y; Matsumura H; Seki H
    BMJ Case Rep; 2013 May; 2013():. PubMed ID: 23709148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Prospective, Single-Arm, Multicenter Trial of Ultrasound-Facilitated, Catheter-Directed, Low-Dose Fibrinolysis for Acute Massive and Submassive Pulmonary Embolism: The SEATTLE II Study.
    Piazza G; Hohlfelder B; Jaff MR; Ouriel K; Engelhardt TC; Sterling KM; Jones NJ; Gurley JC; Bhatheja R; Kennedy RJ; Goswami N; Natarajan K; Rundback J; Sadiq IR; Liu SK; Bhalla N; Raja ML; Weinstock BS; Cynamon J; Elmasri FF; Garcia MJ; Kumar M; Ayerdi J; Soukas P; Kuo W; Liu PY; Goldhaber SZ;
    JACC Cardiovasc Interv; 2015 Aug; 8(10):1382-1392. PubMed ID: 26315743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.